Rhelion Life Sciences Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	8.47	12.27	14.17	18.49	26.09
Short-Term Investments	0.58	-	-	0.05	0.53
Cash & Short-Term Investments	9.05	12.27	14.17	18.53	26.62
Cash Growth	-26.24%	-13.40%	-23.53%	-30.39%	-18.54%
Accounts Receivable	0.45	0.4	0.52	0.52	0.38
Other Receivables	0.03	0	0.52	0.37	0.14
Receivables	0.48	0.4	1.04	0.88	0.52
Inventory	0.85	1	0.87	0.74	0.38
Prepaid Expenses	0.18	0.49	0.78	2.05	0.22
Restricted Cash	-	0.57	0.2	-	-
Other Current Assets	1.9	-	-	-	-
Total Current Assets	12.46	14.74	17.07	22.21	27.75
Property, Plant & Equipment	1.52	5.68	5.66	5.39	3.08
Long-Term Investments	0.6	0.78	1.02	0.87	0.68
Goodwill	-	-	0.28	1.31	0.72
Other Intangible Assets	-	0.02	0.05	0.34	0.59
Other Long-Term Assets	-	-	-	0.03	0.11
Total Assets	14.57	21.22	24.08	30.14	32.94
Accounts Payable	0.63	0.63	0.92	0.62	0.46
Accrued Expenses	1.3	0.74	0.76	0.67	0.92
Short-Term Debt	1.13	1.13	0.91	0.91	0.91
Current Portion of Long-Term Debt	-	0.65	0.39	0.26	0.39
Current Portion of Leases	0.06	0.08	0.13	0.18	0.06
Current Income Taxes Payable	-	0.03	0	-	-
Other Current Liabilities	-	-	0.01	0.05	-
Total Current Liabilities	3.13	3.26	3.12	2.68	2.73
Long-Term Leases	0.22	0.32	0.29	0.42	0.15
Long-Term Deferred Tax Liabilities	-	0.3	0.41	0.51	0.6
Other Long-Term Liabilities	-	-	-	0.19	0.29
Total Liabilities	3.35	3.87	3.82	3.8	3.78
Common Stock	43.84	43.34	42.44	41.79	38.29
Additional Paid-In Capital	5.29	5.12	4.93	3.83	4.76
Retained Earnings	-48.3	-42.2	-38.14	-30.53	-25.13
Comprehensive Income & Other	11.14	11.09	10.84	10.98	10.57
Total Common Equity	11.97	17.35	20.07	26.06	28.48
Minority Interest	-0.75	-0	0.19	0.28	0.68
Shareholders' Equity	11.22	17.35	20.26	26.34	29.16
Total Liabilities & Equity	14.57	21.22	24.08	30.14	32.94
Total Debt	1.42	2.18	1.72	1.77	1.5
Net Cash (Debt)	8.23	10.87	13.48	17.63	25.8
Net Cash Growth	-24.25%	-19.37%	-23.55%	-31.67%	-19.15%
Net Cash Per Share	0.02	0.03	0.03	0.05	0.07
Filing Date Shares Outstanding	614.12	412.25	393.79	387.89	358.17
Total Common Shares Outstanding	425.71	410.85	393.79	387.89	358.17
Working Capital	9.33	11.48	13.95	19.52	25.02
Book Value Per Share	0.03	0.04	0.05	0.07	0.08
Tangible Book Value	11.97	17.33	19.74	24.41	27.16
Tangible Book Value Per Share	0.03	0.04	0.05	0.06	0.08
Land	0.02	1.94	-	1.57	0.04
Buildings	1.25	2.94	3.07	2.97	2.49
Machinery	1.03	1.25	2.76	0.64	0.49
Leasehold Improvements	-	-	-	-	0.02